SCHEMBL19625372

SCHEMBL19625372

CCN(CC)c1ccc(-c2cnc(C(C)(C)C)s2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 2/20 0.37
GFER P55789 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 2/20 0.37
PSMD14 O00487 1/20 0.37
CYP3A4 P08684 1/20 0.37
RECQL P46063 1/20 0.37
MAPT P10636 6/20 0.35
NPC1 O15118 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
RAB9A P51151 3/20 0.35
CNR2 P34972 2/20 0.35
VCP P55072 1/20 0.35
ALDH3A1 P30838 1/20 0.35
ALDH1A3 P47895 1/20 0.35
KDM4E B2RXH2 4/20 0.35
LMNA P02545 3/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11055776 0.80 HSD17B1 (0.43) ALDH1A1L3MBTL1MAPK1GFERTDP1
SCHEMBL19627008 0.80 AOC3 (0.43) ALDH1A1L3MBTL1MAPK1GFERTDP1
SCHEMBL19625352 0.77 KDR (0.39) ALDH1A1L3MBTL1MAPK1TSHRCYP3A4
SCHEMBL19625368 0.77 NPC1 (0.49) ALDH1A1TDP1CYP3A4MAPTNPC1
SCHEMBL26014402 0.76 ABL1 (0.42) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL2600055 0.76 ABL1 (0.42) ALDH1A1MAPK1MAPTNPC1SMN1; SMN2
SCHEMBL10219845 0.75 KDR (0.47) CYP3A4SLC6A3
SCHEMBL889119 0.74 RAB9A (0.40) ALDH1A1L3MBTL1TSHRCYP3A4MAPT
SCHEMBL18760851 0.72 SLC6A3 (0.40) SLC6A3
SCHEMBL19625521 0.71 ALDH1A1 (0.40) ALDH1A1L3MBTL1MAPK1GFERTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885L3MBTL1 2626/4885MAPK1 920/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885L3MBTL1 2626/4885MAPK1 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.